Direct oral anticoagulants; a review for the non-specialist
Thrombin inhibitors and direct factor Xa inhibitors represent a major breakthrough in the field of anticoagulation pharmacotherapy. These novel agents have replaced warfarin as the oral anticoagulant of choice in certain indications, as they possess equal or superior efficacy and better safety prof...
Saved in:
Main Author: | Thilina Gunawardena |
---|---|
Format: | article |
Language: | EN |
Published: |
PAGEPress Publications
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/fe609b572aae45f58e3bad1e170569c7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
by: Joseph R. Shaw, et al.
Published: (2020) -
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
by: Turagam MK, et al.
Published: (2015) -
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
by: Jana Úlehlová, et al.
Published: (2021) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021) -
Nuevos anticoagulantes orales en la prevención del ataque cerebrovascular
by: Soto V,Álvaro, et al.
Published: (2012)